Literature DB >> 2074447

Immunological differentiation between neuroborreliosis and multiple sclerosis.

J Heller1, G Holzer, K Schimrigk.   

Abstract

Neuroborreliosis, a tick-borne spirochaetosis of the central nervous system, is diagnosed by the presence of intrathecally synthesized Borrelia burgdorferi-specific antibodies. Multiple sclerosis and neuroborreliosis can show similarities in clinical symptoms as well as lymphocytic cell reactions and oligoclonal bands in the isoelectric focusing of cerebrospinal fluid. To differentiate between multiple sclerosis and neuroborreliosis we tested intrathecally synthesized IgM and virus antibodies. The IgM indices were higher for most of the neuroborreliosis patients studied than for those with multiple sclerosis, and cell counts were also significantly higher in the acute stage of the disease. In 84% of multiple sclerosis patients we were able to demonstrate intrathecal antibody production against measles, rubella or mumps virus. Neuroborreliosis patients had no intrathecal virus antibody synthesis. The specification of oligoclonal bands resulting from isoelectric focusing of cerebrospinal fluid with an ELISA for B. burgdorferi can further substantiate the diagnosis of neuroborreliosis or help to rule it out in multiple sclerosis patients with positive borrelia-specific serology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2074447     DOI: 10.1007/BF00314763

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

Authors:  K Felgenhauer; H J Schädlich; M Nekic; R Ackermann
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

2.  Borrelia burgdorferi antibodies in multiple sclerosis patients.

Authors:  P K Coyle
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

3.  Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

Authors:  H Reiber; K Felgenhauer
Journal:  Clin Chim Acta       Date:  1987-03-30       Impact factor: 3.786

4.  The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid.

Authors:  H Reiber
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

5.  Estimation of IgM in cerebrospinal fluid by enzyme immunoassay.

Authors:  J Brouwer; T van Leeuwen-Herberts
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

6.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

7.  Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients.

Authors:  P Ukkonen; M L Granström; J Räsänen; E M Salonen; K Penttinen
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

8.  Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis.

Authors:  E Schmutzhard; P Pohl; G Stanek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

9.  Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years.

Authors:  H Krüger; K Reuss; M Pulz; E Rohrbach; K W Pflughaupt; R Martin; H G Mertens
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

10.  Polyneuritis cranialis associated with Borrelia burgdorferi.

Authors:  E Schmutzhard; G Stanek; P Pohl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

View more
  3 in total

Review 1.  [Neuroborreliosis].

Authors:  R Kaiser; V Fingerle
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

2.  Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.

Authors:  K H Rand; H Houck; N D Denslow; K M Heilman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

3.  A case of chronic progressive lyme encephalitis as a manifestation of late lyme neuroborreliosis.

Authors:  Vivek Verma; Matthew Roman; Disha Shah; Marina Zaretskaya; Mohamed H Yassin
Journal:  Infect Dis Rep       Date:  2014-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.